TerminatedNCT01504659
Intranasal Ketamine In the Treatment of Pediatric Bipolarity
Medication studyAges 6–12United States
Understand this study
Who could participate?
Listed age limits: 6 years to 12 years.
- Listed locations
- Not Predetermined and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 5
- Sponsor
- Juvenile Bipolar Research Foundation
- Sponsor type
- Non-profit organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT01504659
- Official title
Show the full official title
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Not Predetermined · Maplewood
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Juvenile Bipolar Research Foundation.
Does this study involve medication?
Yes. The study involves medication, including Ketamine hydrochloride injection and Flat tonic water (e.g., Canada Dry Tonic Water).
Who can participate?
Listed age limits: 6 years to 12 years.
Is this study still recruiting?
The registry lists this study as terminated.
